{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:24:04Z","timestamp":1780050244087,"version":"3.53.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T00:00:00Z","timestamp":1658534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T00:00:00Z","timestamp":1658534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Research Program on Emerging and Re-emerging Infectious Diseases from the Japan Agency for Medical Research and Development","award":["21fk0108604j0001"],"award-info":[{"award-number":["21fk0108604j0001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Spread of vancomycin-resistant <jats:italic>Enterococcus<\/jats:italic> (VRE) is a global concern as a significant cause of healthcare-associated infections. A series of VR<jats:italic>E faecium<\/jats:italic> (VREf) outbreaks caused by clonal propagation due to interhospital transmission occurred in six general hospitals in Aomori prefecture, Japan.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The number of patients with VREf was obtained from thirty seven hospitals participating in the local network of Aomori prefecture. Thirteen hospitals performed active screening tests for VRE. Whole genome sequencing analysis was performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The total number of cases with VREf amounted to 500 in fourteen hospitals in Aomori from Jan 2018 to April 2021. It took more than three years for the frequency of detection of VRE to return to pre-outbreak levels. The duration and size of outbreaks differed between hospitals according to the countermeasures available at each hospital. Whole genome sequencing analysis indicated <jats:italic>vanA<\/jats:italic>-type VREf ST1421 for most samples from six hospitals.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This was the first multi-jurisdictional outbreak of VREf sequence type 1421 in Japan. In addition to strict infection control measures, continuous monitoring of VRE detection in local medical regions and smooth and immediate communication among hospitals are required to prevent VREf outbreaks.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13756-022-01136-5","type":"journal-article","created":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T11:02:43Z","timestamp":1658574163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Interhospital transmission of vancomycin-resistant Enterococcus faecium in Aomori, Japan"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2239-6846","authenticated-orcid":false,"given":"Norihiro","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Kitazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Minakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamichi","family":"Itoga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichiro","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satowa","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzo","family":"Hisatsune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoyuki","family":"Sugai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kayaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,23]]},"reference":[{"key":"1136_CR1","unstructured":"Centers for Disease Control and Prevention. Biggest threats and data. https:\/\/www.cdc.gov\/drugresistance\/biggest-threats.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fdrugresistance%2Fbiggest_threats.html (accessed March 24 2021)"},{"key":"1136_CR2","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1128\/CMR.13.4.686","volume":"13","author":"Y Cetinkaya","year":"2000","unstructured":"Cetinkaya Y, Falk P, Mayhall CG. Vancomycin-resistant enterococci. Clin Microbiol Rev. 2000;13:686\u2013707. https:\/\/doi.org\/10.1128\/CMR.13.4.686.","journal-title":"Clin Microbiol Rev"},{"key":"1136_CR3","unstructured":"European Centre for Disease Prevention and Control (ECDC). Surveillance of antimicrobial resistance in Europe, 2020. Surveillance report 18 Nov 2021."},{"key":"1136_CR4","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s10156-008-0628-x","volume":"14","author":"T Hoshuyama","year":"2008","unstructured":"Hoshuyama T, Moriguchi H, Muratani T, et al. Vancomycin-resistant enterococci outbreak at a university hospital in Kitakyushu, Japan: case-control studies. J Infect Chemother. 2008;14:354\u201360. https:\/\/doi.org\/10.1007\/s10156-008-0628-x.","journal-title":"J Infect Chemother"},{"key":"1136_CR5","unstructured":"Japan nosocomial infections surveillance Sankairyousisetu Ichiran (in Japanese). https:\/\/janis.mhlw.go.jp\/hospitallist\/index.html (Accessed March 26 2021)"},{"key":"1136_CR6","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1186\/s12913-018-3604-x","volume":"18","author":"A Tsutsui","year":"2018","unstructured":"Tsutsui A, Suzuki S. Japan nosocomial infections surveillance (JANIS): a model of sustainable national antimicrobial resistance surveillance based on hospital diagnostic microbiology laboratories. BMC Health Serv Res. 2018;18:799. https:\/\/doi.org\/10.1186\/s12913-018-3604-x.","journal-title":"BMC Health Serv Res"},{"key":"1136_CR7","unstructured":"Japan Nosocomial Infection Surveillance (JANIS) website. https:\/\/janis.mhlw.go.jp\/"},{"key":"1136_CR8","unstructured":"Act on the Prevention of Infectious Diseases and Medical Care for Patients with Infectious Diseases. Act No. 114 of October 2, 1998. http:\/\/www.japaneselawtranslation.go.jp\/law\/detail_main?re=&vm=02&id=2830"},{"key":"1136_CR9","unstructured":"Shovill v1.0.9 . https:\/\/github.com\/tseemann\/shovill"},{"key":"1136_CR10","unstructured":"The staramr v0.7.2. https:\/\/github.com\/phac-nml\/staramr"},{"key":"1136_CR11","unstructured":"The pipeline Snippy v4.4.5. https:\/\/github.com\/tseemann\/snippy"},{"key":"1136_CR12","unstructured":"FigTree v1.4.4. http:\/\/tree.bio.ed.ac.uk\/software\/figtree\/"},{"key":"1136_CR13","unstructured":"Vancomycin-resistant enterococci rates by country, CDDEP, https:\/\/cddep.org\/tool\/vancomycin_resistant_enterococci_rates_country\/ (Accessed on March 26, 2021)"},{"key":"1136_CR14","unstructured":"Japan nosocomial infections surveillance (CLSI2012 version), Clinical Laboratory Division. Annual open report 2019, https:\/\/janis.mhlw.go.jp\/english\/report\/open_report\/2019\/3\/1\/ken_Open_Report_Eng_201900_clsi2012.pdf (accessed March 24, 2021)"},{"key":"1136_CR15","unstructured":"European Centre for Disease Prevention and Control. Data collection and analysis. https:\/\/www.ecdc.europa.eu\/en\/about-us\/networks\/disease-networks-and-laboratory-networks\/ears-net-data"},{"key":"1136_CR16","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1016\/j.ijid.2012.09.019","volume":"17","author":"KM Sohn","year":"2013","unstructured":"Sohn KM, Peck KR, Joo EJ, et al. Duration of colonization and risk factors for prolonged carriage of vancomycin-resistant enterococci after discharge from the hospital. Int J Infect Dis. 2013;17:e240-246. https:\/\/doi.org\/10.1016\/j.ijid.2012.09.019.","journal-title":"Int J Infect Dis"},{"key":"1136_CR17","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1086\/502410","volume":"25","author":"KJ Christiansen","year":"2004","unstructured":"Christiansen KJ, Tibbett PA, Beresford W, et al. Eradication of a large outbreak of a single strain of vanB vancomycin-resistant Enterococcus faecium at a major Australian teaching hospital. Infect Control Hosp Epidemiol. 2004;25:384\u201390. https:\/\/doi.org\/10.1086\/502410.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1136_CR18","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ajic.2007.06.005","volume":"36","author":"A Kurup","year":"2008","unstructured":"Kurup A, Chlebicki MP, Ling ML, et al. Control of a hospital-wide vancomycin-resistant enterococci outbreak. Am J Infect Control. 2008;36:206\u201311. https:\/\/doi.org\/10.1016\/j.ajic.2007.06.005.","journal-title":"Am J Infect Control"},{"key":"1136_CR19","doi-asserted-by":"publisher","first-page":"20229","DOI":"10.2807\/ese.17.30.20229-en","volume":"17","author":"S Fournier","year":"2012","unstructured":"Fournier S, Brossier F, Fortineau N, et al. Long-term control of vancomycin-resistant Enterococcus faecium at the scale of a large multihospital institution: a seven-year experience. Euro Surveill. 2012;17:20229.","journal-title":"Euro Surveill"},{"key":"1136_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13756-018-0335-z","volume":"7","author":"AA Mahony","year":"2018","unstructured":"Mahony AA, Buultjens AH, Ballard SA, et al. Vancomycin-resistant Enterococcus faecium sequence type 796 - rapid international dissemination of a new epidemic clone. Antimicrob Resist Infect Control. 2018;7:44. https:\/\/doi.org\/10.1186\/s13756-018-0335-z.","journal-title":"Antimicrob Resist Infect Control"},{"key":"1136_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/1471-2334-13-163","volume":"13","author":"SC Lee","year":"2013","unstructured":"Lee SC, Wu MS, Shih HJ, et al. Identification of vancomycin-resistant enterococci clones and inter-hospital spread during an outbreak in Taiwan. BMC Infect Dis. 2013;13:163. https:\/\/doi.org\/10.1186\/1471-2334-13-163.","journal-title":"BMC Infect Dis"},{"key":"1136_CR22","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s10096-011-1412-x","volume":"31","author":"A Matsushima","year":"2012","unstructured":"Matsushima A, Takakura S, Yamamoto M, et al. Regional spread and control of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Kyoto, Japan. Eur J Clin Microbiol Infect Dis. 2012;31:1095\u2013100. https:\/\/doi.org\/10.1007\/s10096-011-1412-x.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1136_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2017","volume":"3","author":"N Ulrich","year":"2017","unstructured":"Ulrich N, Vonberg RP, Gastmeier P. Outbreaks caused by vancomycin-resistant Enterococcus faecium in hematology and oncology departments: a systematic review. Heliyon. 2017;3: e00473. https:\/\/doi.org\/10.1016\/j.heliyon.2017.","journal-title":"Heliyon"},{"key":"1136_CR24","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3349\/ymj.2009.50.5.637","volume":"50","author":"YK Yoon","year":"2009","unstructured":"Yoon YK, Sim HS, Kim JY, et al. Epidemiology and control of an outbreak of vancomycin-resistant enterococci in the intensive care units. Yonsei Med J. 2009;50:637\u201343. https:\/\/doi.org\/10.3349\/ymj.2009.50.5.637.","journal-title":"Yonsei Med J"},{"key":"1136_CR25","doi-asserted-by":"publisher","first-page":"140","DOI":"10.12809\/hkmj164939","volume":"23","author":"CKC Lai","year":"2017","unstructured":"Lai CKC, Wong SYN, Lee SS, et al. A hospital-wide screening programme to control an outbreak of vancomycin-resistant enterococci in a large tertiary hospital in Hong Kong. Hong Kong Med J. 2017;23:140\u20139. https:\/\/doi.org\/10.12809\/hkmj164939.","journal-title":"Hong Kong Med J."},{"key":"1136_CR26","doi-asserted-by":"publisher","first-page":"e216","DOI":"10.1016\/j.jhin.2018.02.016","volume":"100","author":"FN Frakking","year":"2018","unstructured":"Frakking FN. Recommendations for the successful control of a large outbreak of vancomycin-resistant Enterococcus faecium in a non-endemic hospital setting. J Hosp Infect. 2018;100:e216-225. https:\/\/doi.org\/10.1016\/j.jhin.2018.02.016.","journal-title":"J Hosp Infect"},{"key":"1136_CR27","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1001\/archinte.162.19.2223","volume":"162","author":"Y Carmeli","year":"2002","unstructured":"Carmeli Y, Eliopoulos G, Mozaffari E, et al. Health and economic outcomes of vancomycin-resistant enterococci. Arch Intern Med. 2002;162:2223\u20138. https:\/\/doi.org\/10.1001\/archinte.162.19.2223.","journal-title":"Arch Intern Med"},{"key":"1136_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/2047-2994-2-18","volume":"2","author":"L Escaut","year":"2013","unstructured":"Escaut L, Bouam S, Frank-Soltysiak M, et al. Eradication of an outbreak of vancomycin-resistant enterococcus (VRE): the cost of a failure in the systematic screening. Antimicrob Resist Infect Control. 2013;2:18. https:\/\/doi.org\/10.1186\/2047-2994-2-18.","journal-title":"Antimicrob Resist Infect Control"},{"key":"1136_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-017-0291-z","volume":"7","author":"L Puchter","year":"2018","unstructured":"Puchter L, Chaberny IF, Schwab F, et al. Economic burden of nosocomial infections caused by vancomycin-resistant enterococci. Antimicrob Resist Infect Control. 2018;7:1. https:\/\/doi.org\/10.1186\/s13756-017-0291-z.","journal-title":"Antimicrob Resist Infect Control"},{"key":"1136_CR30","doi-asserted-by":"publisher","first-page":"7634528","DOI":"10.1155\/2019\/7634528","volume":"5","author":"H Jia","year":"2019","unstructured":"Jia H, Li W, Hou T, et al. The attributable direct medical cost of healthcare associated infection caused by multidrug resistance organisms in 68 hospitals of China. Biomed Res Int. 2019;5:7634528. https:\/\/doi.org\/10.1155\/2019\/7634528.","journal-title":"Biomed Res Int"},{"key":"1136_CR31","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jhin.2013.06.016","volume":"85","author":"P Lloyd-Smith","year":"2013","unstructured":"Lloyd-Smith P, Younger J, Lloyd-Smith E, et al. Economic analysis of vancomycin-resistant enterococci at a Canadian hospital: assessing attributable cost and length of stay. J Hosp Infect. 2013;85:54\u20139. https:\/\/doi.org\/10.1016\/j.jhin.2013.06.016.","journal-title":"J Hosp Infect"},{"key":"1136_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009029","volume":"6","author":"G Birgand","year":"2016","unstructured":"Birgand G, Leroy C, Nerome S, et al. Costs associated with implementation of a strict policy for controlling spread of highly resistant microorganisms in France. BMJ Open. 2016;6: e009029. https:\/\/doi.org\/10.1136\/bmjopen-2015-009029.","journal-title":"BMJ Open"},{"key":"1136_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jhin.2014.09.002","volume":"88","author":"H Humphreys","year":"2014","unstructured":"Humphreys H. Controlling the spread of vancomycin-resistant enterococci. Is active screening worthwhile? J Hosp Infect. 2014;88:191\u20138. https:\/\/doi.org\/10.1016\/j.jhin.2014.09.002.","journal-title":"J Hosp Infect"},{"key":"1136_CR34","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1093\/jac\/dkw314","volume":"71","author":"GP Carter","year":"2016","unstructured":"Carter GP, Buultjens AH, Ballard SA, et al. Emergence of endemic MLST non-typeable vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother. 2016;71:3367\u201371. https:\/\/doi.org\/10.1093\/jac\/dkw314.","journal-title":"J Antimicrob Chemother"},{"key":"1136_CR35","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1101\/gr.204024.116","volume":"26","author":"KE Raven","year":"2016","unstructured":"Raven KE, Reuter S, Reynolds S, et al. A decade of genomic history for healthcare-associated Enterococcus faecium in the United Kingdom and Ireland. Genome Res. 2016;26:1388\u201396. https:\/\/doi.org\/10.1101\/gr.204024.116.","journal-title":"Genome Res"},{"key":"1136_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0218185","author":"K Lemonidis","year":"2019","unstructured":"Lemonidis K, Salih TS, Dancer SJ, et al. Emergence of an Australian-like pstS-null vancomycin resistant Enterococcus faecium clone in Scotland. PLoS One. 2019. https:\/\/doi.org\/10.1371\/journal.pone.0218185.","journal-title":"PLoS One"},{"key":"1136_CR37","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1093\/jac\/dky308","volume":"73","author":"TA Hansen","year":"2018","unstructured":"Hansen TA, Pedersen MS, Nielsen LG, et al. Emergence of a vancomycin-variable Enterococcus faecium ST1421 strain containing a deletion in vanX. J Antimicrob Chemother. 2018;73:2936\u201340. https:\/\/doi.org\/10.1093\/jac\/dky308.","journal-title":"J Antimicrob Chemother"},{"key":"1136_CR38","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1007\/s10096-020-03853-4","volume":"39","author":"KM Kim","year":"2020","unstructured":"Kim KM, Chung DR, Choet SY, et al. Emergence of vancomycin-resistant Enterococcus faecium ST1421 lacking the pstS gene in Korea. Eur J Clin Microbiol Infect Dis. 2020;39:1349\u201356. https:\/\/doi.org\/10.1007\/s10096-020-03853-4.","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01136-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-022-01136-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-022-01136-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T11:15:30Z","timestamp":1658574930000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-022-01136-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,23]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1136"],"URL":"https:\/\/doi.org\/10.1186\/s13756-022-01136-5","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,23]]},"assertion":[{"value":"22 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Hirosaki University Graduate School of Medicine (approval number 2019-1012). Patient consent was not required because of the retrospective nature of the study, which was based entirely on anonymized data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}